Roche drops Herceptin patent extension bid in India

Roche has decided not to pursue a patent extension until 2019 in India for its blockbuster cancer drug, Herceptin, clearing the way for generic drug makers to manufacture the drug.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news